52.80
-0.96
(-1.79%)
At close: January 10 at 4:00:02 PM EST
52.80
0.00
(0.00%)
After hours: January 10 at 5:59:19 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 6 | 4 |
| Avg. Estimate | 1.16 | 0.96 | 4.13 | 5 |
| Low Estimate | 1.11 | 0.85 | 4.08 | 4.63 |
| High Estimate | 1.23 | 1.08 | 4.19 | 5.19 |
| Year Ago EPS | 0.82 | 0.79 | 2.77 | 4.13 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 4 | 9 | 7 |
| Avg. Estimate | 285.91M | 231.17M | 1B | 1.18B |
| Low Estimate | 270M | 220.88M | 987.35M | 1.15B |
| High Estimate | 306.27M | 245.79M | 1.02B | 1.21B |
| Year Ago Sales | 230.04M | 195.88M | 829.25M | 1B |
| Sales Growth (year/est) | 24.29% | 18.02% | 21.02% | 17.45% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.83 | 0.7 | 0.76 | 1 |
| EPS Actual | 0.82 | 0.79 | 0.91 | 1.27 |
| Difference | -0.01 | 0.09 | 0.15 | 0.27 |
| Surprise % | -1.44% | 13.57% | 20.10% | 27.05% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.16 | 0.96 | 4.13 | 5 |
| 7 Days Ago | 1.17 | 1.08 | 4.14 | 4.69 |
| 30 Days Ago | 1.2 | 1.07 | 4.13 | 4.68 |
| 60 Days Ago | 1.2 | 1.07 | 4.13 | 4.79 |
| 90 Days Ago | 1.27 | 1.06 | 3.95 | 4.75 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HALO | 41.32% | 21.84% | 49.02% | 21.16% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Neutral to Neutral | 1/10/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/20/2024 |
Related Tickers
BMRN BioMarin Pharmaceutical Inc.
67.38
-1.46%
EXEL Exelixis, Inc.
36.02
+4.41%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
CPRX Catalyst Pharmaceuticals, Inc.
21.92
-3.86%
PGEN Precigen, Inc.
1.1750
-0.42%
JANX Janux Therapeutics, Inc.
46.76
-7.99%
ADMA ADMA Biologics, Inc.
18.56
0.00%
VRNA Verona Pharma plc
45.20
-2.16%
INCY Incyte Corporation
70.54
-3.54%
FOLD Amicus Therapeutics, Inc.
9.02
-4.65%